GSK plc

GSK plc ROE

The Return on Equity (ROE) of GSK plc (GSK.L) as of Sep 17, 2026 is 34.90 %. In the previous year, Return on Equity (ROE) was 18.84 % — a change of 85.30% (higher).

ROE

34.90 %

YoY

85.30%

Last updated:

In 2026, GSK plc's return on equity (ROE) was 34.90 %, a 85.30% increase from the 18.84 % ROE in the previous year.

The GSK plc ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
95.82 GBP
Jan 1, 2019
40.73 GBP
Jan 1, 2020
39.41 GBP
Jan 1, 2021
29.13 GBP
Jan 1, 2022
141.12 GBP
Jan 1, 2023
36.92 GBP
Jan 1, 2024
18.84 GBP
Jan 1, 2025
34.90 GBP
The GSK plc ROE history
YEARROEYoY
34.90 %+85.30%
18.84 %-48.99%
36.92 %-73.84%
141.12 %+384.51%
29.13 %-26.10%
39.41 %-3.23%
40.73 %-57.50%
95.82 %-104.25%
-2,252.94 %-2,876.65%
81.14 %-50.73%
164.69 %+154.74%
64.65 %—
Access this data via the Eulerpool API
Get Free API Key

GSK plc Stock analysis

What does GSK plc do? GSK plc is one of the most popular companies on Eulerpool.

ROE Details

Decoding GSK plc's Return on Equity (ROE)

GSK plc's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing GSK plc's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

GSK plc's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in GSK plc’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about GSK plc stock

Return on Equity (ROE) of GSK plc is 34.90 % in 2026.

Return on Equity (ROE) of GSK plc changed from 18.84 % to 34.90 %, representing a 85.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) GSK plc since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s GSK plc with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — GSK plc

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — GSK plc